Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance)
- Citation:
- Cancer Res vol 76 (4 Suppl) S2-05
- Meeting Instance:
- SABCS 2015
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- William M Sikov
- Authors:
- William M Sikov Donald A Berry Charles M Perou Baljit Singh Constance T Cirrincione Sara M Tolaney Charles S Kuzma Timothy J Pluard George Somlo Elisa R Port Mehra Golshan Jennifer R Bellon Deborah Collyar Olwen M Hahn Lisa A Carey Clifford A Hudis Eric P Winer
- Networks:
- CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: